[HTML][HTML] A3-adenosine receptors: design of selective ligands and therapeutic prospects
KA Jacobson, HO Kim, SM Siddiqi, ME Olah… - Drugs of the …, 1995 - ncbi.nlm.nih.gov
Adenosine A1 and A2 receptors have been the subject of intense activity in the
pharmaceutical industry. Adenosine agonists, which are almost exclusively derivatives of …
pharmaceutical industry. Adenosine agonists, which are almost exclusively derivatives of …
A3-adenosine receptors: design of selective ligands and therapeutic prospects.
KA Jacobson, HO Kim, SM Siddiqi, ME Olah… - Drugs of the …, 1995 - europepmc.org
Adenosine A1 and A2 receptors have been the subject of intense activity in the
pharmaceutical industry. Adenosine agonists, which are almost exclusively derivatives of …
pharmaceutical industry. Adenosine agonists, which are almost exclusively derivatives of …
[引用][C] A3-adenosine receptors: Design of selective ligands and therapeutic prospects
KA Jacobson, HO Kim, SM Siddiqi, ME Olah… - Drugs of the …, 1995 - cir.nii.ac.jp
[引用][C] A3-adenosine receptors: design of selective ligands and therapeutic prospects
KA Jacobson, HO Kim, SM Siddiqi… - Drugs of the …, 1995 - pubmed.ncbi.nlm.nih.gov
A3-adenosine receptors: design of selective ligands and therapeutic prospects.
KA Jacobson, HO Kim, SM Siddiqi, ME Olah… - Drugs of the …, 1995 - europepmc.org
Adenosine A 1 and A 2 receptors have been the subject of intense activity in the
pharmaceutical industry. Adenosine agonists, which are almost exclusively derivatives of …
pharmaceutical industry. Adenosine agonists, which are almost exclusively derivatives of …